Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVOTHYROXINE Cause Product physical issue? 220 Reports in FDA Database

Thyroid Balance & Feminine Wellness

Thyrafemme Balance — 14 gentle ingredients for energy, mood & hormonal harmony.

Discover Thyrafemme

According to the FDA Adverse Event Reporting System (FAERS), 220 reports of Product physical issue have been filed in association with LEVOTHYROXINE (LEVOTHYROXINE SODIUM). This represents 0.4% of all adverse event reports for LEVOTHYROXINE.

220
Reports of Product physical issue with LEVOTHYROXINE
0.4%
of all LEVOTHYROXINE reports
0
Deaths
15
Hospitalizations

How Dangerous Is Product physical issue From LEVOTHYROXINE?

Of the 220 reports, 15 (6.8%) required hospitalization, and 4 (1.8%) were considered life-threatening.

Is Product physical issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVOTHYROXINE. However, 220 reports have been filed with the FAERS database.

What Other Side Effects Does LEVOTHYROXINE Cause?

Fatigue (10,494) Headache (6,425) Insomnia (4,663) Drug ineffective (4,556) Alopecia (4,491) Weight increased (4,130) Nausea (4,013) Palpitations (3,825) Dizziness (3,761) Asthenia (3,694)

What Other Drugs Cause Product physical issue?

SUMATRIPTAN (2,349) TIOTROPIUM (807) ICOSAPENT ETHYL (666) LISDEXAMFETAMINE DIMESYLATE (652) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (387) IBUPROFEN (337) ESTRADIOL\LEVONORGESTREL (305) ESTRADIOL (302) RUXOLITINIB (302) IXAZOMIB (298)

Which LEVOTHYROXINE Alternatives Have Lower Product physical issue Risk?

LEVOTHYROXINE vs LEVOTHYROXINE\LEVOTHYROXINE LEVOTHYROXINE vs LEVOTHYROXINE\LIOTHYRONINE LEVOTHYROXINE vs LEVOXYL LEVOTHYROXINE vs LEXAPRO LEVOTHYROXINE vs LEXISCAN

Related Pages

LEVOTHYROXINE Full Profile All Product physical issue Reports All Drugs Causing Product physical issue LEVOTHYROXINE Demographics